Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jan 3, 2022
Date Accepted: Feb 25, 2023
Evaluation of two AI software for CXR Screening and PTB Diagnosis : A Study Protocol
ABSTRACT
Background:
Tuberculosis (TB) profile in Malaysia showed an average annual growth rate of 2.23%, with an estimated 92 cases per 100,000 people reported in 2018. CXR remains the best conventional method for the early detection of pulmonary TB infection. The intervention of AI in TB diagnosis could efficiently aid human interpreters and reduce health professionals' work burden. To date, no evaluation of AI studies has been carried out in Malaysia.
Objective:
This study aims to determine the diagnostic accuracy and evaluate the performance of Qure.ai and Putra Analytica AI software.
Methods:
We will conduct a retrospective case-control study in Respiratory Medicine Institute (IPR), Kuala Lumpur Health Clinic and Bandar Botanik Klang Health Clinic. Patients' medical reports on TB investigation will be retrieved by accessing electronic and hardcopy medical records and collecting demographic data. Prior to conducting the study, patients' PTB status will be obtained by identifying MTB culture (reference standard) results in order to create a case and a control group. A total of 2000 CXR images will be retrieved, of which 1000 images will be the case (abnormality). Normal and abnormal CXR will be categorized into film and digital CXR, which will be screened onto the said AI software (index tests).
Results:
Results obtained from the AI software will be compared with the reference standard, and significant statistical analysis will be computed
Conclusions:
We hope that the findings of this evaluation study will provide sufficient information for stakeholders and to implement AI technology in the medical imaging field for better management of TB in hospital and clinic settings.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.